drugset / Trial / NCT03608514
Terlipressin Alone Versus the Standard Therapy With Catecholamines for Hepatic Patients With Septic Shock- Prospective Single Center Randomized Controlled Study.
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the use of terlipressin compared to standard regimen in hepatic patients with septic shock. Another aim is to compare the mortality rate \& the effects on renal functions in both groups.
Timeline
- Start
- 2018-07-01
- Primary completion
- 2020-07
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Terlipressin | Peptide | 1 ug/kg | Intravenous |
| Subject | Terlipressin | Peptide | 2 ug/kg | Intravenous |
Indications
No indication recorded.